In case of prostate cancer, potential PET/MRI indications are staging in patients with a positive biopsy, assessment of tumor recurrence after treatment in patients with increasing PSA, and tumor detection in case of increased PSA but negative biopsies [31]. This evidence concerns the gene KLK3 and neoplasm.